To report expanded SD-OCT findings of HCQ retinopathy that may assist the clinician in earlier diagnosis. To characterize structural changes of HCQ retinopathy with SD-OCT after drug cessation. Anti malarial medication hydroxychloroquine Bob & aralene goldberg foundation Plaquenil mouth sores Hydroxychloroquine Plaquenil; HCQ has been an important and effective drug for the treatment of lupus erythematosus and related autoimmune and inflammatory diseases for half a century, although its potential to cause retinal damage continues to raise concern among rheumatologists and ophthalmologists. Plaquenil hydroxychloroquine belongs to a group of medicines called quinolines. Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Hydroxychloroquine HCQ has been used for therapy of rheumatologic disorders since the 1950s. The American Academy of Ophthalmology revised the screening guidelines in 2011 to include spectral domain-optical coherence tomography SD-OCT, fundus autofluorescence FAF, and multifocal ERG. If there were SD-OCT images available that. Retrospective clinical data review by the Boston Image Reading Center. Setting: Private practice and academic institution. Patient Population: Patients at New England Eye Center and Ophthalmic Consultants of Boston in Boston, MA diagnosed with HCQ retinopathy and followed after drug cessation. Plaquenil oct images Outer Retinal Layers as Predictors of Vision Loss, Plaquenil Uses, Dosage & Side Effects - Plaquenil and radiation therapyHydroxychloroquine mnemonicHydroxychloroquine and skin rashPlaquenil genetic risk test The junction remains in the fovea white arrow. When this thinning is translated into an OCT map, a bulls-eye pattern of thinning is manifested, as shown in the image entitled "Time Domain OCT Map in Hydroxychloroquine Toxicity". The patient shown here is the same one shown in the image "Asymmetric Hydroxychloroquine Plaquenil Retinal Toxicity". Time Domain OCT in Hydroxychloroquine Plaquenil Toxicity.. Expanded spectral domain-OCT findings in the early.. Eye screening for patients taking hydroxychloroquine Plaquenil®. Autofluorescence imaging allows for earlier diagnosis of retinal dystrophies. the image in the area that’s affected will be brighter than the corresponding normal zones, and this is typically. Hydroxychloroquine, sold under the brand name Plaquenil Sanofi-Aventis, is an antimalarial drug that has gained widespread use in treating various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. 1 By some estimates, more than 150,000 patients are on long-term therapy with this medication in America alone. 2 Retinal toxicity associated with HCQ use is. Results SD-OCT images demonstrated loss of photoreceptor inner segment/outer segment IS/OS junction and a downward “sink-hole” displacement of inner retinal structures in areas of hydroxychloroquine toxicity corresponding to HVF 10-2 defects and ophthalmoscopic clinical examination findings.